Your browser doesn't support javascript.
loading
Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: A phase III randomized controlled trial.
Sperl, Jan; Horvath, Gabor; Halota, Waldemar; Ruiz-Tapiador, Juan Arenas; Streinu-Cercel, Anca; Jancoriene, Ligita; Werling, Klara; Kileng, Hege; Koklu, Seyfettin; Gerstoft, Jan; Urbanek, Petr; Flisiak, Robert; Leiva, Rafael; Kazenaite, Edita; Prinzing, Renate; Patel, Sushma; Qiu, Jingjun; Asante-Appiah, Ernest; Wahl, Janice; Nguyen, Bach-Yen; Barr, Eliav; Platt, Heather L.
Afiliación
  • Sperl J; Institut Klinické a Experimentální Medicíny (IKEM), Prague, Czech Republic. Electronic address: jase@medicon.cz.
  • Horvath G; Budai Hepatólogiai Centrum, Budapest, Hungary.
  • Halota W; Department of Infectious Diseases and Hepatology, Faculty of Medicine, Nicolaus Copernicus University, Bydgoszcz, Poland.
  • Ruiz-Tapiador JA; Hospital Universitario Donostia, Gipuzkoa, Spain.
  • Streinu-Cercel A; Carol Davila University of Medicine and Pharmacy, National Institute for Infectious Diseases "Prof. Dr. Matei Balș", Bucharest, Romania.
  • Jancoriene L; Vilnius University, Department of Infectious and Chest Diseases, Dermatovenerology and Alergology, Vilnius University Hospital Santariskiu Klinikos, Vilnius, Lithuania.
  • Werling K; Semmelweis Egyetem, Budapest, Hungary.
  • Kileng H; UNN Universitetssykehuset Nord Norge, Tromsø, Norway.
  • Koklu S; Hacettepe University Medical Faculty, Ankara, Turkey.
  • Gerstoft J; Klinik for Infektionsmedicin, Rigshospitalet, University of Copenhagen, Denmark.
  • Urbanek P; Department of Internal Medicine, 1st Medical Faculty Charles University and Central Military Hospital, Prague, Czech Republic.
  • Flisiak R; Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Bialystok, Poland.
  • Leiva R; Haukeland University Hospital, Bergen, Norway.
  • Kazenaite E; Vilnius University, Faculty of Medicine, Vilnius University Hospital Santariskiu Klinikos, Vilnius, Lithuania.
  • Prinzing R; Merck & Co., Inc., Kenilworth, NJ, United States.
  • Patel S; Merck & Co., Inc., Kenilworth, NJ, United States.
  • Qiu J; Merck & Co., Inc., Kenilworth, NJ, United States.
  • Asante-Appiah E; Merck & Co., Inc., Kenilworth, NJ, United States.
  • Wahl J; Merck & Co., Inc., Kenilworth, NJ, United States.
  • Nguyen BY; Merck & Co., Inc., Kenilworth, NJ, United States.
  • Barr E; Merck & Co., Inc., Kenilworth, NJ, United States.
  • Platt HL; Merck & Co., Inc., Kenilworth, NJ, United States.
J Hepatol ; 65(6): 1112-1119, 2016 12.
Article en En | MEDLINE | ID: mdl-27542322
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Hepatitis C Crónica Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2016 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Hepatitis C Crónica Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2016 Tipo del documento: Article